Majid Barekatain
Overview
Explore the profile of Majid Barekatain including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
233
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Shahpouri M, Barekatain M, Tavakoli M, Mirmosayyeb O, Safaei A, Shaygannejad V
Neurol Res Int
. 2020 Dec;
2020:8874424.
PMID: 33299606
Background: Multiple sclerosis (MS) is a demyelinating disease of the central nervous system that affects cognitive performance and leads to depression and decreased quality of life (QOL). The current study...
12.
Ghanbari S, Haghani F, Barekatain M, Jamali A
J Educ Health Promot
. 2020 Sep;
9:176.
PMID: 32953905
Introduction: To design instructions in health sciences education, it is highly relevant to heed the working memory and the approaches for managing cognitive load. In this article, we tried to...
13.
Karami M, Nilipour R, Barekatain M, Gaillard W
Iran J Child Neurol
. 2020 Sep;
14(3):7-18.
PMID: 32952578
As one of the most common neurological diseases in children, epilepsy affects 0.9-2% of children. Complex interactions among the etiologies of epilepsy, interictal discharges, seizures, and antiepileptic drugs lead to...
14.
Gharipour M, Barekatain M, Sung J, Emami N, Sadeghian L, Dianatkhah M, et al.
Int J Mol Sci
. 2020 Sep;
21(18).
PMID: 32942585
(1) Background: Obesity and mood disorders are considered as the most prevalent morbidities in many countries. We suppose that epigenetic mechanisms may induce higher rates of obesity in subjects who...
15.
Shahpouri M, Barekatain M, Tavakoli M, Badihian S, Shaygannejad V
Int J Prev Med
. 2020 Aug;
11:69.
PMID: 32742613
Background: Cognitive impairment is one of the debilitating consequences of multiple sclerosis (MS) with negative effects on daily life, individual and social activities, quality of life (QOL), and depression. No...
16.
Firoozeei T, Barekatain M, Karimi M, Zargaran A, Akhondzadeh S, Rezaeizadeh H
J Integr Med
. 2020 Aug;
18(5):409-415.
PMID: 32739466
Background: Major depressive disorder (MDD) accompanied by anxious distress is a chronic and disabling disorder. Its conventional drug therapies often have low patient compliance due to drug-related side effects. In...
17.
Zahed S, Emami M, Eslami A, Barekatain M, Hassanzadeh A, Zamani-Alavijeh F
J Educ Health Promot
. 2020 Jun;
9:65.
PMID: 32490000
Background: Caregiver stress is harmful to the health of both caregivers and people living with Alzheimer's disease or other dementias. The present study was conducted to assess stress and its...
18.
Zare M, Habibabadi J, Moein H, Barekatain M, Basiratnia R, Tofangsazi L
Adv Biomed Res
. 2020 Feb;
9:3.
PMID: 32055537
Background: We conducted a study to evaluate the relationship between aura types and postoperative outcomes in patients with mesial temporal sclerosis (MTS) to predict the prognosis of patients, accordingly. Materials...
19.
Shahpouri M, Barekatain M, Tavakoli M, Sanaei S, Shaygannejad V
J Res Med Sci
. 2020 Jan;
24:110.
PMID: 31949461
Background: Multiple sclerosis (MS) can involve cognitive entities, including memory, attention, performance, and information processing. Furthermore, MS causes depression and negatively affects the quality of life (QOL). This study was...
20.
Zahed S, Emami M, Bazargan-Hejazi S, Eslami A, Barekatain M, Zamani-Alavijeh F
BMC Palliat Care
. 2019 Nov;
18(1):105.
PMID: 31779612
Background: The burden of caring for People with Dementia (PWD) is heavy; identifying incentives that motivate them in providing care is essential in facilitating and optimizing care. This study aims...